{"id":50875,"date":"2014-10-18T13:48:15","date_gmt":"2014-10-18T17:48:15","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=50875"},"modified":"2014-10-18T20:30:37","modified_gmt":"2014-10-19T00:30:37","slug":"get-here-however-you-can","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2014\/10\/18\/get-here-however-you-can\/","title":{"rendered":"get here however you can!&#8230;"},"content":{"rendered":"<p align=\"center\"><img decoding=\"async\" border=\"0\"  src=\"http:\/\/1boringoldman.com\/images\/aacap-61.gif\" \/><\/p>\n<p align=\"justify\" class=\"small\">&quot;<em>We look forward to welcoming you to sunny San Diego for AACAP&#8217;s 61st Annual Meeting!<\/em><\/p>\n<p style=\"text-align: center;\"> <object width=\"200\" height=\"160\" name=\"single1\" id=\"single1\" classid=\"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000\"><param name=\"movie\" value=\"http:\/\/aacapphotos.com\/site_videos\/player\/player-viral.swf\"\/><param name=\"allowfullscreen\" value=\"true\"\/><param name=\"allowscriptaccess\" value=\"always\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"flashvars\" value=\"file=http:\/\/aacapphotos.com\/site_videos\/webinars\/annual_meeting\/Welcome_to_San_Diego.flv&amp;image=http:\/\/aacapphotos.com\/site_videos\/webinars\/annual_meeting\/welcome_san_diego_screen.jpg\"\/><embed id=\"single2\" name=\"single2\" type=\"application\/x-shockwave-flash\" src=\"http:\/\/aacapphotos.com\/site_videos\/player\/player-viral.swf\" bgcolor=\"undefined\" allowscriptaccess=\"always\" allowfullscreen=\"true\" wmode=\"transparent\" flashvars=\"file=http:\/\/aacapphotos.com\/site_videos\/webinars\/annual_meeting\/Welcome_to_San_Diego.flv&amp;image=http:\/\/aacapphotos.com\/site_videos\/webinars\/annual_meeting\/welcome_san_diego_screen.jpg\" height=\"160\" width=\"200\"\/><\/object> <\/p>\n<p align=justify class=small>Gabrielle Carlson, MD, AACAP&rsquo;s Program Chair, welcomes you to San Diego  from the USS Midway, the site of the Welcome Reception on Wednesday,  October 22. All are invited to attend!&quot;<\/p>\n<hr size=\"1\" \/>\n<p align=\"justify\">In the spirited video from the deck of the USS Midway, Gabrielle Carlson sporting a sailor&#8217;s cap, welcomes us to <a href=\"http:\/\/www.aacap.org\/AnnualMeeting\/2014\" target=\"_blank\">the AACAP Annual Meeting<\/a>, ending with the words, &quot;<em>Get here however you can!<\/em>&quot; You may not recognize her name right off. Here&#8217;s a reminder:<\/p>\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" border=\"0\" width=\"520\" height=\"174\" src=\"http:\/\/1boringoldman.com\/images\/carson.gif\" \/><\/p>\n<div align=\"justify\">Is it fair to haunt Dr. Carlson with her being an author on the by-line of the infamous Paxil Study 329 report in the <font color=\"#200020\">Journal of the American Academy of Child and Adolescent Psychiatry<\/font> back in 2001? She is, after all, a <a target=\"_blank\" href=\"http:\/\/medicine.stonybrookmedicine.edu\/psychiatry\/faculty\/carlson_g\">valued academic<\/a> at Stony Brook, decorated for her research contributions in psychopharmacology. She&#8217;s obviously right-thinking on some areas of the issue of over medicating children. In a recent <em>Commentary<\/em>, she decries the overmedication with Atypical Antipsychotics&#8230;<\/div>\n<blockquote>\n<div align=\"center\" class=\"big\"><strong><font color=\"#200020\">The Dramatic Rise in Neuroleptic Use In Children:<br \/>   Why Do We Do It and What Does It Buy Us?<br \/>   Theories from Inpatient Data 1988-2010 <\/font><\/strong><\/div>\n<div align=\"center\" class=\"small\">by Gabrielle A. Carlson, MD<\/div>\n<div align=\"center\" class=\"middle\"><strong><font color=\"#200020\">JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY<\/font><\/strong> 2013 23[3]:144-147.<\/div>\n<div align=\"center\" class=\"middle\">[<a href=\"http:\/\/medicine.stonybrookmedicine.edu\/system\/files\/neofiles\/carlson_aaps.pdf\" target=\"_blank\">full text on-line<\/a>]<\/div>\n<p align=\"justify\">&#8230;It is ironic that the most noxious and impairing behavior, namely explosive outbursts in children, has no &lsquo;&lsquo;home&rsquo;&rsquo; in the DSM no- sology. Recognizing that explosions can occur in many conditions, neither intermittent explosive disorder nor, if it is accepted into DSM-V, DMDD, allows the diagnosis if the explosions are &lsquo;&lsquo;better explained by&rsquo;&rsquo; another condition. There is not even a consistent way in which one can find information about rage outbursts. In PubMed, there are almost completely different databases for terms like rages, rage outbursts, anger outbursts, rage attacks, explosive outbursts, and meltdowns. Irritability, the term that seems increasingly to be adopted, like aggression, may sub- sume these behaviors, but is not synonymous. Therefore, we speculate that the behavior that most drives the most use of AAPs does not even have a label that can be consistently used, and will certainly, without a &quot;home,&quot; never be an indication for FDA approval&#8230;.<\/p>\n<p align=\"justify\">In conclusion, the meteoric rise in the use of AAPs in children with ADHD and ODD reflects the fact that the traditional evidence-based treatments (stimulants and parent training\/behavior modification) are either unsupported by providers and insurance (at least in terms of the intensity they require) or that these treatments are insufficient, because of the severity of the conditions being treated.<\/p>\n<div align=\"justify\">AAPs may be expensive, and clearly have important adverse effects. The question is whether society (and insurance companies) want to support the alternatives. If they do not, I feel that the rhetoric is disingenuous. I, for one, would be grateful if the AAPs could compensate for what we have lost in terms of other treatments, and were as powerful as the media imply.<\/div>\n<\/blockquote>\n<div align=\"justify\">&#8230; blaming the Managed Care payers for not supporting more appropriate treatments. Good for her.<\/div>\n<p align=\"justify\">However, I not only think that haunting these <em>authors<\/em> is justified, but is actually an imperative. Twenty of the twenty-two authors of Study 329 are still alive, six are in significant leadership positions in the <font color=\"#200020\">American Academy of Child and Adolescent Psychiatry<\/font>, and others dot the by-lines of other ghost-written industry-funded experimercials like this one. Gabrielle Carlson is AACAP&#8217;s Program Chair welcoming the attendees to the meeting. It is likely that many of the named authors were on the by-line of that article only because they were site primary investigators for the clinical trial itself and little involved in the writing or the extensive data manipulation involved in creating this masterpiece of deceit &#8211; now a monument to an era yet to be fully acknowledged. <\/p>\n<p align=\"justify\"><img decoding=\"async\" border=\"1\" align=\"right\" width=\"182\" hspace=\"4\" src=\"http:\/\/1boringoldman.com\/images\/carlson.jpg\" \/>In the case of Dr. Carlson, Stony Brook was in the group of sites added to Paxil Study 329 late because of slow recruitment and accounted for only 11 subjects in the trial. She&#8217;s not mentioned in any of the subpoenaed documents that I know of. Apparently it was simply a source of revenue for Stony Book, and another paper to add to her CV. But that&#8217;s the whole point. Other than the two SKB\/GSK employees who directed the show creating the paper with ghost-writer Sally Laden, the actual non-involvement was true for the twenty academic authors whose names were on that <em>author<\/em>&#8216;s list. They lent their academic credentials and the reputations of their institutions to the paper, a ticket insuring that it would be accepted in a prestigious journal and read by colleagues who respected those honorifics, without really participating in its creation. But even worse, in the decade during which the paper has been universally vilified, not one of those authors has come forward and said a word. They continue to occupy high places, adding an obvious irony to Carlson&#8217;s comment, <em><font color=\"#200020\">&quot;Get here however you can!&quot;<\/font><\/em><\/p>\n<p align=\"justify\">Sure, Managed Care bureaucrats have pushed atypical antipsychotics over more intensive and expensive interventions [<em>keeping the cost of medical care down<\/em>]. Of course the Pharmaceutical Industry has promoted antidepressant medications for treatment of adolescent depression [<em>in the business of selling FDA approved drugs<\/em>]. Yes the professional organizations have created guidelines that recommend these practices [<em>evidence-based medicine from peer-reviewed journals<\/em>]. But without those names on the by-line certifying the articles, the papers wouldn&#8217;t have been published that allowed those things to happen. And when the authors sit in silence in their own careers even after it becomes clear, as in this case, that they lent their names, positions, and institutions to a fictional publication, they are the main force in the center of perpetuating what&#8217;s wrong.<\/p>\n<div align=\"justify\">So, is it fair to haunt Dr. Carlson with her being an author on the by-line of the infamous Paxil Study 329 report in the <font color=\"#200020\">Journal of the American Academy of Child and Adolescent Psychiatry<\/font> back in 2001? Of course it is. The whole profession and the patients we serve are haunted by publications like Paxil Study 329, and will continue to be haunted until&nbsp; these authors, this journal, this organization, and this profession wakes up and starts talking and making needed changes&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&quot;We look forward to welcoming you to sunny San Diego for AACAP&#8217;s 61st Annual Meeting! Gabrielle Carlson, MD, AACAP&rsquo;s Program Chair, welcomes you to San Diego from the USS Midway, the site of the Welcome Reception on Wednesday, October 22. All are invited to attend!&quot; In the spirited video from the deck of the USS [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-50875","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/50875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=50875"}],"version-history":[{"count":31,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/50875\/revisions"}],"predecessor-version":[{"id":50908,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/50875\/revisions\/50908"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=50875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=50875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=50875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}